Eli Lilly's popular obesity drug Zepbound can now be covered by government-backed Medicare drug plans, the Centers for ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

It opens the door for broader coverage and access to Zepbound, which is not currently covered by Medicare and many other ...

Eli Lilly's popular obesity drug Zepbound can now be covered by government-backed Medicare drug plans, CNBC reported on ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 484.89% and ...

Despite the study confirming that Yellowstone’s magma is more solid than liquid, Michael Poland emphasized the need to focus on more immediate risks and hazards in the park rather than ...

U.S. women's national team head coach Emma Hayes will have 50 players participate in a massive winter event during January.

Liverpool legend, Steven Gerrard, has finally spoken about the rumors that his 20-year-old daughter Lilly-Ella is expecting a ...

The move intensifies an ongoing legal battle, as Novo Nordisk joins its major competitor Eli Lilly in opposing a recent initiative by the Outsourcing Facilities Association to include liraglutide in ...

If innovative cancer therapies were the top launches to watch in 2024, this year’s high-profile biopharma debuts is slated to ...

The health benefits of time-restricted eating go beyond weight loss and may be most prominent in patients already with ...